TY  - GEN
AU  - Hrustanovic,Gorjan
AU  - Olivas,Victor
AU  - Pazarentzos,Evangelos
AU  - Tulpule,Asmin
AU  - Asthana,Saurabh
AU  - Blakely,Collin M
AU  - Okimoto,Ross A
AU  - Lin,Luping
AU  - Neel,Dana S
AU  - Sabnis,Amit
AU  - Flanagan,Jennifer
AU  - Chan,Elton
AU  - Varella-Garcia,Marileila
AU  - Aisner,Dara L
AU  - Vaishnavi,Aria
AU  - Ou,Sai-Hong I
AU  - Collisson,Eric A
AU  - Ichihara,Eiki
AU  - Mack,Philip C
AU  - Lovly,Christine M
AU  - Karachaliou,Niki
AU  - Rosell,Rafael
AU  - Riess,Jonathan W
AU  - Doebele,Robert C
AU  - Bivona,Trever G
TI  - RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer
SN  - 1546-170X
PY  - 2015///1208
KW  - Anaplastic Lymphoma Kinase
KW  - Cell Line, Tumor
KW  - Drug Resistance, Neoplasm
KW  - Dual Specificity Phosphatase 6
KW  - physiology
KW  - Humans
KW  - Lung Neoplasms
KW  - drug therapy
KW  - Mitogen-Activated Protein Kinase Kinases
KW  - antagonists & inhibitors
KW  - Mitogen-Activated Protein Kinases
KW  - Oncogene Proteins, Fusion
KW  - analysis
KW  - Proto-Oncogene Proteins
KW  - genetics
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Receptor Protein-Tyrosine Kinases
KW  - ras Proteins
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/nm.3930
ER  -